Rpo LLC Makes New $54,000 Investment in agilon health, inc. (NYSE:AGL)

Rpo LLC bought a new stake in agilon health, inc. (NYSE:AGL) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 28,206 shares of the company’s stock, valued at approximately $54,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of AGL. Vanguard Group Inc. grew its holdings in shares of agilon health by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock worth $59,114,000 after acquiring an additional 272,787 shares during the period. State Street Corp boosted its position in agilon health by 3.0% during the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after purchasing an additional 215,733 shares in the last quarter. Geode Capital Management LLC grew its holdings in agilon health by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock valued at $13,168,000 after purchasing an additional 35,207 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of agilon health by 49.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock valued at $8,629,000 after buying an additional 1,498,524 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after buying an additional 1,083,492 shares during the last quarter.

agilon health Stock Performance

NYSE AGL opened at $4.06 on Thursday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $1.67 billion, a PE ratio of -4.32 and a beta of 0.67. The business’s 50-day moving average price is $3.72 and its 200 day moving average price is $2.99. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $7.73.

Analyst Ratings Changes

Several research firms recently commented on AGL. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and increased their price objective for the company from $1.75 to $2.25 in a research note on Friday, January 10th. Sanford C. Bernstein increased their price target on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Stifel Nicolaus upped their target price on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research note on Wednesday, February 26th. Finally, Royal Bank of Canada raised their price target on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research report on Wednesday, February 26th. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $3.95.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.